| 000 | 02062cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031203.0 | ||
| 008 | 150329s2014 ua f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.18.M.Sc.2014.Ma.C | ||
| 100 | 0 | _aMay Mostafa Ramadan | |
| 245 | 1 | 0 |
_aCMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD / _cMay Mostafa Ramadan ; Supervised Nadia Elshamy , Manal Eldeeb |
| 246 | 1 | 5 | _aأمراض الكلى و تأثير فيروسات الدم على وظائفها و تأثير الفيروسات بالدم على إحتياج العقار ايريثروبيوتين فى علاج انيميا الكلى المزمنة |
| 260 |
_aCairo : _bMay Mostafa Ramadan , _c2014 |
||
| 300 |
_a111 P. ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine | ||
| 520 | _aChronic kidney disease is a worldwide problem , the prevalence of the disease is increasing due to increasing of the patients lifespan and the increasing of the available screening and investigation techniques. The outcome of the disease is related to its early diagnosis and management. Anemia of CKD has many causes. It plays an important role in morbidity, so treatment is important. The management of anemia of CKD which is a complication of ckd due to erythropoietin deficiency is very important and affecting the mortality outcomes of CKD. The management of anemia with oral iron supplementation, intravenous iron, blood transfusion and erythropoietin has their recently guidelines definitions which aims at maintaining haemoglobin concentration > 11 g / dl | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aCKD | |
| 653 | 4 | _aCMV | |
| 653 | 4 | _aHemoglobin | |
| 700 | 0 |
_aManal Eldeeb , _eSupervisor |
|
| 700 | 0 |
_aNadia Elshamy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c50107 _d50107 |
||